ANALYTIC LUNG CANCER by CLASS N = 351 Class 0: Dx’d at JHH only 1: Dx’d at JHH and received all/part of 1st course tx at JHH 2: Dx’d at an outside facility.

Slides:



Advertisements
Similar presentations
I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=
Advertisements

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=
Prostate Cancer Cancer: Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer.
What is cancer? A cancer is a malignant tumor, which are cells that multiply out of control, destroying healthy tissues (Dictionary)
Breast Cancer By: Vincent Russo And Scott Jeffery.
TYPES, CAUSES, SYMPTOMS, TREATMENTS, STATISTICS, & PICTURES HEATHER XXXXXXX, 1 ST PERIOD Lung Cancer 1
BREAST CANCER OVERVIEW Polly Stephens, M.D.. BREAST ANATOMY.
FEMALE BREAST CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/03/20014.
Lung Cancer Emily Cauchon Katie Reeves Emily Cauchon Katie Reeves.
THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/02/2013.
PROSTATE CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.
MELANOMA JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.
Definitive chemo-radiotherapy for esophageal cancer; failure pattern and salvage treatments Ryuta Koike, Y. Nishimura, K. Nakamatsu, S. Kanamori, M. Okubo,
LUNG CANCER Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases n=1364 Analytic - Initially Diagnosed and/or received all.
PANCREATIC CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY 2009.
Urinary Tract System Bladder Cancer.
THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.
What is cancer? Mitosis- normal cell division Cancer- uncontrolled cell division (carcinoma) –Develops into a tumor Benign- does not spread –(Not Cancerous)
1 Sarcoma Ages >= ** Analytic - Initially Diagnosed and/or received all or part of 1st course treatment at.
GASTRIC CANCER JHH Johns Hopkins Hospital Gastric Cancer , All Cases n=317 Analytic - Initially Diagnosed and/or received all or.
Cell Processes & Energy Cancer Chapter 2 Section 4.
HEAD/NECK CARCINOMA Johns Hopkins Hospital.
Radical vs Partial Nephrectomy for treatment of renal cell carcinoma at Prince Hussein Urology Centre Dr. Mohammad Alserhan Urology specialist Prince Hussein.
Quality & Sustainability in Cancer Control: A System Performance Spotlight Report To use a hyperlink, right click on it and select ‘Open Hyperlink’, or.
Presented at the NAACCR Annual Conference Quebec City June 22, 2010.
Johns Hopkins Hospital Cancer Registry Melanoma
JHH Prostate Cancer Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.
Lung Cancer.
Lung Cancer Angel.
Regulating the cell cycle
Supplemental Figure 1: FOXM1 mRNA level analysis in 48 ovarian tissues
NON-SMALL CELL LUNG CANCER
A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.
Ductal Carcinoma (Breast Cancer)
Lung squamous cell carcinoma
JOHNS HOPKINS HOSPITAL CANCER REGISTRY
Johns Hopkins Hospital Malignant and Benign Brain/CNS
A graph of the 15-year survival curves comparing localized melanoma (Stages I and II), regional metastases (Stage III), and distant metastases (Stage IV).
JOHNS HOPKINS CANCER REGISTRY 2009
ANALYTIC PANCREATIC CANCER by CLASS N = 369
Johns Hopkins Hospital Cancer Registry
Staging system for gastric carcinoma
Prognosis of younger patients in non-small cell lung cancer
Marcelo Calil Instituto Brasileiro de Controle do Câncer
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Table 1 Baseline patient characteristics
Staging Cancer.
The IASLC Lung Cancer Database
تهیه کننده: استاد مربوطه: بهار 1392
The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer
Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002  Antonio L Visbal, MD, Brent.
Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival  Elizabeth A. David, MD, Robert J. Canter,
Supplemental Figure 1: Kaplan-Meier Curves of overall survival based on clinical stage at presentation and treatment modality Kaplan-Meier analyses depicting.
Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis
Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A
4155 primary hepatocellular carcinoma with known diagnosis month/year
Joshua E. Rosen, BASc, Michelle C
Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer  Shawn S. Groth, MD, MS, Natasha.
Thymoma: A Population-Based Study of the Management and Outcomes for the Province of British Columbia  Caroline Mariano, MD, Diana N. Ionescu, MD, Winson.
Solving Equations 3x+7 –7 13 –7 =.
Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q
Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.
Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer  Thomas W Rice, MD, David J Adelstein, MD, Jay P Ciezki,
Should Large Cell Neuroendocrine Lung Carcinoma be Classified and Treated as a Small Cell Lung Cancer or with Other Large Cell Carcinomas?  John M. Varlotto,
A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.
Data Analytics course.
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Trends in survival from metastatic lung cancer in California,
Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study  Robert J. Cerfolio, MD, Ayesha.
Machine learning analysis for predicting survival in stage III non-small cell lung cancer patients receiving definitive chemotherapy and proton radiation.
Presentation transcript:

ANALYTIC LUNG CANCER by CLASS N = 351 Class 0: Dx’d at JHH only 1: Dx’d at JHH and received all/part of 1st course tx at JHH 2: Dx’d at an outside facility and all/part of 1st course tx at JHH

ANALYTIC LUNG CANCER by RACE N = 351

ANALYTIC LUNG CANCER AGE AT DIAGNOSIS by GENDER N = 351

ANALYTIC LUNG CANCER by AJCC STAGE at DIAGNOSIS N = 351

ANALYTIC LUNG CANCER by HISTOLOGY N = 351 Other types include 19 Carcinoma, NOS, 1 spindle cell and 1 carcinosarcoma

ANALYTIC SMALL CELL LUNG CANCER CLASS 1&2* by TREATMENT/AJCC STAGE n=38 AJCC IAJCC IIAJCC IIIAJCC IVTOTAL NO TREATMENT10001 CHEMOTHERAPY00156 RADIATION00011 RADIATION CHEMOTHERAPY SURGERY00112 SURGERY CHEMOTHERAPY SURGERY RADIATION CHEMOTHERAPY TOTAL *3 Class 0 not included

ANALYTIC NON SMALL CELL LUNG CANCER CLASS 1&2* by TREATMENT AJCC STAGE I N=77 *3 Class 3 not included

ANALYTIC NON SMALL CELL LUNG CANCER CLASS 1&2 by TREATMENT AJCC STAGE II N=20 *1 Class 0 not included

ANALYTIC NON SMALL CELL LUNG CANCER CLASS 1&2 by TREATMENT AJCC STAGE III N=65 *4 Class 0 not included

ANALYTIC NON SMALL CELL LUNG CANCER CLASS 1&2 by TREATMENT AJCC STAGE IV N=99 *2 Class 0 not included

NON SMALL CELL LUNG CANCER OBSERVED SURVIVAL, JHH by AJCC STAGE

NON SMALL CELL LUNG CANCER OBSERVED SURVIVAL ©2009 National Cancer Data Base/Commission on Cancer

SMALL CELL LUNG CANCER OBSERVED SURVIVAL, JHH by AJCC STAGE

SMALL CELL LUNG CANCER OBSERVED SURVIVAL ©2009 National Cancer Data Base/Commission on Cancer